Optimi Health announces the launch of six nootropic supplements derived from functional mushrooms.
Small Pharma Inc.: World’s First Clinical Trial For DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I
This analysis provides additional insight into dose-related effects on the primary outcomes of safety and tolerability.
The Future of Psychedelic Medicine: Two DIFFERENT Treatment Models
Spiritual journey or clinical therapy? What does the future of psychedelic medicine look like?
Gold price closing in on $1,900
Gold prices jumped to an eight-month high on Thursday, closing in on the key $1,900 /oz mark.
PharmaTher Announces Grant of U.S. Patent on Ketamine Formulation
Pharmather announces a method of use and composition of matter patent from the USPTO for its proprietary ketamine formulation, KETABET(TM).
Optimi Health Approved to Supply Psilocybin Under Health Canada’s Special Access Program
Optimi Health's subsidiary has been named an approved supplier of psilocybin for Health Canada's SAP access program.
Mindset Pharma Identifies New Pharmacological Insights of First Generation Psychedelics Through its COPE Program with InterVivo Solutions
Mindset announces new insights in research on psychedelics molecules via its COPE initiative.
Novamind Advances Clinical Pilot for Frontline KAP
Novamind announces a "clinical pilot" aimed at bringing ketamine-assisted therapy to treat the mental health disorders of frontline healthcare workers.
Field Trip Health Ltd. Reports Third Fiscal Quarter 2022 Financial Results and Provides Business Update
During the quarter, Field Trip progressed its strategy of building the leading psychedelic therapy company through its Field Trip Health division and continued to invest in its lead drug development program.
Hawaii Senators Approve Psilocybin Task Force Bill In Committee, With Decriminalization Measures Still Pending
A Hawaii Senate committee on Friday approved a bill to set up a state working group to study the therapeutic benefits of psilocybin mushrooms.
Price gains for gold, silver on safe-haven demand
Gold and silver futures prices are higher in early U.S. trading Monday, with gold notching a nearly three-month high.
Psychedelic Medicine For PTSD: The Key To U.S. Legal Reforms
There are many valid reasons to push forward with legal reforms to advance psychedelic medicine. In the U.S., however, it is the treatment of PTSD that is bringing Republicans and Democrats together.
